{
    "applicationNumber": "BR 11 2012 007374-5",
    "filingDate": "23/09/2010",
    "grantDate": null,
    "title": "COMPOSI\u00c7\u00c3O, FORMULA\u00c7\u00c3O ORAL, INJET\u00c1VEL, INAL\u00c1VEL OU NEBULIZ\u00c1VEL, E, \u00c1CIDO NUCLEICO ISOLADO OU RECOMBINANTE",
    "nationalPhaseDate": [
        "30/03/2012"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2010/064020",
        "pctDate": "23/09/2010",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "US",
            "priorityNumber": "61/247346",
            "priorityDate": "30/09/2009"
        }
    ],
    "events": [
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2542"
        },
        {
            "code": "8.6",
            "description": "Arquivamento - Art. 86 da LPI",
            "bulletinNumber ": "2543"
        },
        {
            "code": "8.11",
            "description": "Manuten\u00e7\u00e3o do Arquivamento",
            "bulletinNumber ": "2559"
        }
    ],
    "inventors": [
        "BRUCE HAMILTON",
        "CHRISTOPHER HERRING",
        "MARK ANDREW PAULIK"
    ],
    "holders": [
        81128
    ],
    "ipcCodes": [
        "A61K 39/395",
        "C07K 16/18",
        "C07K 14/575",
        "A61P 5/48",
        "A61P 3/08",
        "C07K 14/605",
        "A61K 47/48"
    ]
}